Cargando…

Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration

BACKGROUND: Staphylococcus aureus is one of the major causes of bloodstream infections (BSI) worldwide, representing a major challenge for public health due to its resistance profile. Higher vancomycin minimum inhibitory concentrations (MIC) in S. aureus are associated with treatment failure and def...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Costa, Thaina Miranda, Cuba, Gabriel Trova, Morgado, Priscylla Guimarães Migueres, Nicolau, David P., Nouér, Simone Aranha, dos Santos, Kátia Regina Netto, Kiffer, Carlos Roberto Veiga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979379/ https://www.ncbi.nlm.nih.gov/pubmed/31973753 http://dx.doi.org/10.1186/s12879-020-4782-9

Ejemplares similares

Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital
por: da Costa, Thaina Miranda, et al.
Publicado: (2016)

Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital
por: Damasco, Andreia Paredes, et al.
Publicado: (2019)

Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract
por: Cuba, Gabriel Trova, et al.
Publicado: (2014)

Complete substitution of the Brazilian endemic clone by other methicillin-resistant Staphylococcus aureus lineages in two public hospitals in Rio de Janeiro, Brazil
por: Chamon, Raiane Cardoso, et al.
Publicado: (2016)

Pandemic clone USA300 in a Brazilian hospital: detection of an emergent lineage among methicillin-resistant Staphylococcus aureus isolates from bloodstream infections
por: Augusto, Mariana Fernandes, et al.
Publicado: (2022)

Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Ruczyński, Jarosław, et al.
Publicado: (2019)

1643. Pharmacodynamics (PD) of Daptomycin (DAP) in Combination Therapy for Enterococcal Bloodstream Infection (BSI)
por: Avery, Lindsay, et al.
Publicado: (2018)

Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in Iran
por: Ataee, Ramezan Ali, et al.
Publicado: (2014)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023)

Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in Staphylococcus aureus
por: Chavva, Hasitha, et al.
Publicado: (2023)

Systemic infection caused by the methicillin-resistant Staphylococcus aureus USA300-LV lineage in a Brazilian child previously colonized
por: Whitaker, Carolina de Oliveira, et al.
Publicado: (2023)

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
por: Kara, Ahu, et al.
Publicado: (2014)

Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
por: Beneri, Christy A, et al.
Publicado: (2008)

Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling
por: Song, Xiangqing, et al.
Publicado: (2021)

Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
por: García de la Mària, Cristina, et al.
Publicado: (2015)

Publisher Correction: Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin
por: Ruczyński, Jarosław, et al.
Publicado: (2019)

Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea
por: Kim, Hee Kyung, et al.
Publicado: (2020)

1110. In Vivo Pharmacodynamics of Vancomycin Against Staphylococci in Young Infants
por: Gwee, Amanda, et al.
Publicado: (2021)

Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus
por: Park, Min-Jeong, et al.
Publicado: (2015)

Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates
por: Shealy, Stephanie C., et al.
Publicado: (2020)

Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens
por: Kiffer, Carlos RV, et al.
Publicado: (2011)

Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
por: Nham, Eliel, et al.
Publicado: (2022)

In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
por: Cuba, Gabriel T., et al.
Publicado: (2022)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
por: Neoh, Hui-min, et al.
Publicado: (2007)

733 Vancomycin-Resistant Enterococcus (VRE) faecium Bloodstream Infections and Mortality
por: Suleyman, Geehan, et al.
Publicado: (2014)

Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections
por: Hemapanpairoa, Jatapat, et al.
Publicado: (2022)

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
por: Srivastava, Shashikant
Publicado: (2015)

A creep in the vancomycin minimum inhibitory concentration for Staphylococcus aureus in a tertiary care hospital in India
por: Bhakta, A, et al.
Publicado: (2011)

Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
por: Aminzadeh, Zohreh, et al.
Publicado: (2014)

Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode
por: Song, Xiangqing, et al.
Publicado: (2022)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
por: Lim, Tze-Peng, et al.
Publicado: (2018)

409 Efficacy of Vancomycin against Biofilms of Neonatal Staphylococcus epidermidis Bloodstream Isolates
por: Simitsopoulou, Maria, et al.
Publicado: (2014)

2322. Reduced Vancomycin Susceptibility Among Pediatric Staphylococcus aureus Bloodstream Infections
por: Ericson, Jessica, et al.
Publicado: (2018)

Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
por: Phillips, Cameron J, et al.
Publicado: (2016)

Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group
por: Wilcox, Mark, et al.
Publicado: (2019)

Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
por: Hadder, Brent, et al.
Publicado: (2022)

Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance–evaluation on an urban health unit
por: Chen, Maggie, et al.
Publicado: (2022)

Pharmacodynamic considerations of collateral sensitivity in design of antibiotic treatment regimen
por: Udekwu, Klas I, et al.
Publicado: (2018)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6pqo3805rh261atpqsjp5fmprr